Sneaky Midsole Pen - Trainer Sneaker Touch Up Marker Paint Pen

Product Information

are aware that this recall also applies to Emerade 300 microgram auto-injectors that are currently held by schools. See further information on the use of pens in school, in the document attached below; Adrenaline is the first line of treatment for serious allergic reactions (anaphylaxis). It is available on prescription in a pre-loaded injection device (known as an adrenaline auto-injector or AAI).

that they need to receive training, so they are confident in being able to use any new devices (see further information in the document attached below); Pharmacists and pharmacies who receive Emerade 300 microgram auto-injectors from patients should quarantine the pens and return them to the supplier using the supplier’s approved process.Get a health professional to show you how to use your AAIs. You can ask your doctor, practice nurse, pharmacist or school nurse to show you how. This is a recall for Emerade 300 microgram pens only. This is a different alert to that issued on 4 March 2020 for Emerade 150 microgram auto-injectors. Results from manufacturer testing of Emerade auto-injectors recalled from patients in Europe indicate that approximately 13% of pens need higher than normal force to activate, implying a higher risk of activation failure than was previously understood. This applies to all strengths of Emerade.

administer an adrenaline auto-injector device without delay, even if there is doubt whether it is anaphylaxis; for the rare scenario where patients might need more than 2 adrenaline pens prescribed (for example, a prior severe reaction resistant to treatment with adrenaline), where the prescriber may issue additional pens. that they should always carry 2 in-date auto-injectors with them at all times in case they need to administer a second dose of adrenaline before the arrival of the emergency services; General Practitioners (GPs) should send the attached Patient Letter – Advice for patients with an Emerade 150 microgram auto-injector to all patients and carers, as appropriate, who have been prescribed Emerade 150 micrograms auto-injectors. Patients and carers should be told of the important differences between brands of adrenaline pen in how they are used.The Medicines and Healthcare Products Regulatory Agency (MHRA) advises people prescribed with an AAI that they should always carry two, in case of an emergency Alternatively, you can report via some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) or by calling the Commission on Human Medicines (CHM) free phone line: 0800-731-6789. It is recommended that you carry two AAIs at all times, this is particularly important for people who have allergic asthma and a food allergy as they are at an increased risk of a severe allergic reaction.1 GPs should also send the attached Patient Letter – Advice for patients with Emerade 300 microgram or Emerade 500 microgram auto-injectors to all patients and carers for information. Actions for healthcare professionals

MHRA Guidelines. Available at https://www.gov.uk/drug-safety-update/adrenaline-auto-injectors-updated-advice-after-european-review. Last Accessed: May 2023 There are three adrenaline auto-injectors (AAIs) available on prescription in the UK. The manufacturers of all three offer free trainer devices so you can practise using your AAI. pharmacists and pharmacies who receive Emerade 150 microgram auto-injectors from patients should quarantine the pens and return to them to their supplier using the supplier’s approved process. General Practitioners (GPs) should send the attached Patient Letter – Advice for patients with an Emerade 150 microgram auto-injector to all patients and carers, as appropriate, who have been prescribed Emerade 150 micrograms auto-injectors. Emerade 500 microgram auto-injectors are not being recalled at present as there are insufficient supplies of alternatives to provide replacements. For all patients currently in possession of Emerade 500 microgram auto-injectors, the advice from MHRA and DHSC remains that the risk to the patient of being left without a pen, and therefore having no adrenaline to administer, is greater than allowing them to keep pens that may not activate, especially if two pens are carried.

Viatris Connect

inform patients to return Emerade 300 microgram auto-injectors to the pharmacy, when they have obtained two adrenaline auto-injectors in a different brand; that they should always carry two in-date auto-injectors with them at all times in case they need to administer a second dose of adrenaline before the arrival of the emergency services; Patients with Emerade 150 microgram auto-injectors should be provided with the supplementary letter and information (see Patient Letter – Advice for patients with an Emerade 150 microgram auto-injector) EpiPen ®(adrenaline)Auto-Injector0.3mgSummaryofProductCharacteristics.Availableat: https://www.medicines.org.uk/emc There are two types of AAIs available in the UK, these are called Epi-Pen and Jext. They both contain the same type of medication called ‘adrenaline’ (also referred to as ‘epinephrine’) which is given by injection, into the outer midthigh muscle. AAIs are prescription only medicines, and need to be prescribed by a healthcare professional –usually your GP or allergy specialist. The dose of adrenaline required is dependent on the age and weight of the person requiring the AAI device, and will be prescribed by the doctor. It is important that AAIs prescribed for children are reviewed as they get older and increase in weight to ensure they have the correct dose. Each AAI device will differ in appearance and the availability of the dose/strength available in that particular brand.

All patients should be made aware of the signs and symptoms of anaphylaxis and that at the first onset of any signs or symptoms of anaphylaxis, they or a carer/bystander should:use a second adrenaline auto-injector immediately if an Emerade pen fails to activate despite pressing firmly against the thigh, see Class 2 Medicines Recall: Emerade 300 micrograms solution for injection in pre-filled syringe, PL 33616/0014 (EL(20)A/20); Store in a cool dark place at room temperature, kept out of direct sunlight and out of the way of extreme temperatures, for example a fridge, or glove box in a car on a hot day. call an ambulance (999) immediately after giving the injection and say this is an emergency case of anaphylaxis;